Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?
Patent expiry trametinib?
Does lipitor's effectiveness decrease with high fat meals?
Patent term adjustment semaglutida?
When is xarelto's patent set to expire roughly?

Letrozole 2.5 uses?

See the DrugPatentWatch profile for Letrozole

Letrozole 2.5 mg – What it’s used for

Letrozole is a non‑steroidal aromatase inhibitor that blocks the conversion of androgens to estrogen. Because it lowers estrogen production, it’s employed in several clinical situations where reducing estrogen is therapeutic. The 2.5 mg tablet is the most commonly prescribed strength.

Indication How it’s used (typical protocol) Key points
Adjuvant therapy for hormone‑receptor‑positive breast cancer (post‑menopausal women) 2.5 mg orally once daily for 5 years (sometimes 3 years) • Reduces risk of cancer recurrence and improves survival.
• Preferred over tamoxifen in many patients due to better tolerability and fewer thromboembolic events.
Preventive therapy in high‑risk, pre‑menopausal women 2.5 mg orally once daily for 3–5 years • Proven to lower incidence of breast cancer in high‑risk groups (e.g., BRCA1/2 carriers, dense breast tissue).
Infertility (ovarian stimulation) – off‑label 2.5 mg daily from cycle day 3–5 until the day of the trigger (or 5 days after trigger for “late” dosing).
• Often combined with a GnRH antagonist.		 • Improves ovarian response and reduces the risk of ovarian hyperstimulation syndrome (OHSS) compared with clomiphene.
• FDA‑approved dose for IVF is 1.25 mg, but many clinics use 2.5 mg.
Gynecomastia (estrogen‑dependent) 2.5 mg daily short‑term (weeks to months) • Reduces breast tissue growth by lowering circulating estrogen.
Transgender hormone therapy (anti‑estrogen effect) 2.5 mg daily (often with testosterone) • Helps prevent feminizing estrogen effects; dosage individualized.
Other estrogen‑dependent conditions (rare) 2.5 mg daily (case reports) • Such as estrogen‑driven fibroids or endometriosis; evidence is limited.

How it works

Letrozole inhibits the aromatase enzyme (CYP19A1), which converts androstenedione and testosterone into estrone and estradiol. By lowering estrogen, it:

  1. Suppresses estrogen‑stimulated tumor growth in breast cancer.
  2. Stimulates the hypothalamus‑pituitary axis → ↑ follicle‑stimulating hormone (FSH) and luteinizing hormone (LH) → increased ovarian follicle development (used in infertility).
  3. Reduces estrogen‑driven breast tissue growth in gynecomastia and transgender patients.

Common side effects

System Symptoms Management tips
Endocrine Hot flashes, night sweats, fatigue Cooling clothing, non‑hormonal meds (e.g., clonidine)
Bone Decreased bone mineral density (especially >5 yrs) Calcium/vitamin D supplements, bone‑strengthening agents if needed
Cardiovascular Minimal risk of clotting vs tamoxifen Monitor cardiovascular risk; avoid in high‑risk thrombotic patients
Other Headache, dizziness, nausea, mood changes Symptomatic relief, dose adjustment if needed

Contraindications & Precautions

  • Pregnancy & lactation – contraindicated.
  • Severe hepatic impairment – reduce dose or avoid.
  • Concurrent estrogen therapy – avoid due to antagonistic effect.
  • Drug interactions – letrozole is metabolized by CYP2A6 and CYP3A4. Concurrent strong inducers (e.g., rifampin, carbamazepine) can lower its levels; inhibitors (e.g., ketoconazole) can increase.
  • Breast cancer patients – monitor tumor markers and imaging.
  • Infertility patients – avoid in women with unexplained infertility where clomiphene remains standard unless specific protocol is requested by a reproductive endocrinologist.

Monitoring

Test Frequency Reason
CBC & CMP Baseline, 3 mo, then every 6 mo Detect bone marrow suppression or liver toxicity
Bone density (DEXA) Baseline, then annually (if >5 yrs therapy) Prevent osteoporosis
Ultrasound/biopsy (breast) As per oncology protocol Check tumor status
FSH/LH/estradiol In infertility protocols Adjust dosing and timing

Bottom line

Letrozole 2.5 mg is a versatile drug primarily used to reduce estrogen levels for:

  • Breast cancer prevention and treatment in post‑menopausal women.
  • Infertility (ovarian stimulation) when clomiphene is ineffective or contraindicated.
  • Gynecomastia and transgender hormone management.

Because it can significantly alter hormone balances, it should only be used under a qualified clinician’s supervision, with appropriate monitoring and attention to contraindications and drug interactions. If you’re considering letrozole for any purpose, discuss the risks, benefits, and alternatives with your healthcare provider.



Other Questions About Letrozole :

letrozole 2.5 mg tablet uses Letrozole brand name? Letrozole pills price? How much does letrozole cost with insurance? Letrozole tablet? Letrozole generic price? Letrozole brand names?